Long-term Follow-up of Stable Kidney Transplant Recipients After Conversion From Tacrolimus Twice Daily Immediate Release to Tacrolimus Once-daily Prolonged Release: A Large Single-Center Experience
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference21 articles.
1. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients;Cross;Drugs,2007
2. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation;Borra;Nephrol Dial Transplant,2010
3. Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation;Trunec̆ka;Am J Transplant,2010
4. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study;Krämer;Am J Transplant,2010
5. Four-year experience with tacrolimus once- daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies;Van Hooff;Clin Transplant,2010
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Calcineurin Inhibitor Toxicity in Solid Organ Transplantation;Pharmacology;2021
2. Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus;Transplantation Proceedings;2020-01
3. Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients;American Journal of Kidney Diseases;2018-03
4. Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials;Transplantation Proceedings;2017-11
5. A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study;American Journal of Transplantation;2016-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3